Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-01

Clinical Trial Update: TIzanidine for the Preventive Treatment of Episodic MigrainE (TIME) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating TIzanidine for preventive treatment of episodic migraine is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TIZANIDINE (TIZANIDINE)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Migraine Without Aura, Migraine With Aura | Phase 3 | Status: RECRUITING